Intelligent Bio Solutions Inc. (INBS)Healthcare | Medical Devices | New York, United States | NasdaqCM
1.45 USD
-0.04
(-2.685%) ⇩
(Oct. 14, 2026, 4 p.m.
EDT)
After hours: 1.52 +0.07 (4.828%) ⇧ (Oct. 14, 2026, 6:14 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 11:21 a.m. EDT
The immediate outlook is severely bearish as the stock trades at multi-year lows, having lost nearly 99.8% of its value over the last four years. Despite recent headlines celebrating FDA progress and manufacturing partnerships, the market has priced in a catastrophic failure of the business model, evidenced by four consecutive years of negative annual returns and a massive gap between the current price and the analyst mean target. Fundamentally, the company is bleeding cash with negative operating margins, negative free cash flow, and negative returns on equity, while trading below book value. There is no dividend to provide income, and the lack of a multi-year price recovery suggests the market views these operational milestones as insufficient to reverse the structural decline. The short-term technicals remain weak, with the price well below both the 50-day and 200-day moving averages, indicating continued downward pressure despite the optimistic news cycle. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.192821 |
| AutoETS | 0.205065 |
| AutoTheta | 0.325346 |
| AutoARIMA | 0.485535 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 0.55 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.459 |
| Excess Kurtosis | -0.33 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 34.383 |
| Revenue per Share | 2.862 |
| Market Cap | 4,809,364 |
| Forward P/E | 4.14 |
| Beta | 4.30 |
| Profit Margins | -294.91% |
| Previous Name | GBS Inc. |
| Website | https://ibs.inc |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.86168224 |
| Address1 | 135 West, 41st Street |
| Address2 | 5th Floor |
| All Time High | 34,176.0 |
| All Time Low | 1.45 |
| Ask | 2.12 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 57,960 |
| Average Daily Volume3 Month | 159,804 |
| Average Volume | 159,804 |
| Average Volume10Days | 57,960 |
| Beta | 4.302 |
| Bid | 1.21 |
| Bid Size | 2 |
| Book Value | 1.897 |
| City | New York |
| Compensation As Of Epoch Date | 1,798,675,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.45 |
| Current Ratio | 1.44 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 1.455 |
| Day Low | 1.35 |
| Debt To Equity | 34.383 |
| Display Name | Intelligent Bio |
| Dividend Yield | 0.0 |
| Ebitda | -11,145,683 |
| Ebitda Margins | -2.64418 |
| Enterprise To Ebitda | -0.166 |
| Enterprise To Revenue | 0.438 |
| Enterprise Value | 1,847,512 |
| Eps Forward | 0.35 |
| Eps Trailing Twelve Months | -8.44 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.0926 |
| Fifty Day Average Change | -0.64260006 |
| Fifty Day Average Change Percent | -0.30708212 |
| Fifty Two Week Change Percent | -86.16822 |
| Fifty Two Week High | 24.9 |
| Fifty Two Week High Change | -23.449999 |
| Fifty Two Week High Change Percent | -0.94176704 |
| Fifty Two Week Low | 1.35 |
| Fifty Two Week Low Change | 0.100000024 |
| Fifty Two Week Low Change Percent | 0.07407409 |
| Fifty Two Week Range | 1.35 - 24.9 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,608,733,800,000 |
| Float Shares | 2,937,009 |
| Forward Eps | 0.35 |
| Forward P E | 4.1428576 |
| Free Cashflow | -6,716,897 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 59 |
| Fullday Change | 0.029999971 |
| Fullday Change Percent | 2.0134208 |
| Fullday Price | 1.52 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.48634 |
| Gross Profits | 2,049,994 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02728 |
| Held Percent Institutions | 0.05468 |
| Implied Shares Outstanding | 3,316,803 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Language | en-US |
| Last Fiscal Year End | 1,782,777,600 |
| Last Split Date | 1,765,843,200 |
| Last Split Factor | 1:10 |
| Long Business Summary | Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York. |
| Long Name | Intelligent Bio Solutions Inc. |
| Market | us_market |
| Market Cap | 4,809,364 |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_578948353 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-10-14 |
| Net Income To Common | -12,430,975 |
| Next Fiscal Year End | 1,814,313,600 |
| Non Diluted Market Cap | 5,870,741 |
| Number Of Analyst Opinions | 1 |
| Open | 1.36 |
| Operating Cashflow | -11,927,222 |
| Operating Margins | -3.4598498 |
| Phone | 646 828 8258 |
| Post Market Change | 0.06999993 |
| Post Market Change Percent | 4.8275814 |
| Post Market Price | 1.52 |
| Post Market Time | 1,792,016,041 |
| Prev Name | GBS Inc. |
| Previous Close | 1.49 |
| Price Hint | 4 |
| Price To Book | 0.76436484 |
| Price To Sales Trailing12 Months | 1.1409643 |
| Profit Margins | -2.9491 |
| Quick Ratio | 1.18 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.03999996 |
| Regular Market Change Percent | -2.6845613 |
| Regular Market Day High | 1.455 |
| Regular Market Day Low | 1.35 |
| Regular Market Day Range | 1.35 - 1.455 |
| Regular Market Open | 1.36 |
| Regular Market Previous Close | 1.49 |
| Regular Market Price | 1.45 |
| Regular Market Time | 1,792,008,001 |
| Regular Market Volume | 95,555 |
| Return On Assets | -0.76204 |
| Return On Equity | -3.0769198 |
| Revenue Growth | 0.358 |
| Revenue Per Share | 2.862 |
| Sand P52 Week Change | 0.17004645 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 3,316,803 |
| Shares Percent Shares Out | 0.0176 |
| Shares Short | 58,294 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 33,673 |
| Short Name | Intelligent Bio Solutions Inc. |
| Short Percent Of Float | 0.018099999 |
| Short Ratio | 0.21 |
| Source Interval | 15 |
| State | NY |
| Symbol | INBS |
| Target High Price | 12.0 |
| Target Low Price | 12.0 |
| Target Mean Price | 12.0 |
| Target Median Price | 12.0 |
| Total Cash | 4,141,470 |
| Total Cash Per Share | 1.368 |
| Total Debt | 1,819,160 |
| Total Revenue | 4,215,175 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -8.44 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.787815 |
| Two Hundred Day Average Change | -2.337815 |
| Two Hundred Day Average Change Percent | -0.6171936 |
| Type Disp | Equity |
| Volume | 95,555 |
| Website | https://ibs.inc |
| Zip | 10,036 |